Oncology

Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
Auditory Nerve Test System During Vestibular Schwannoma Resection
Conditions:   Vestibular Schwannoma;   Acoustic Neuroma;   Sensorineural Hearing Loss;   Asymmetric Sensorineural Hearing Loss;   Cochlear Nerve Damage;   Cochlear Nerve Deafness;   Skull Base Neoplasms;   Auditory; Nerve
Intervention:   Device: Auditory Nerve Test System
Sponsor:   Washington University School of Medicine
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection
Condition:   Breast Cancer Lymphedema
Interventions:   Procedure: Axillary Lymph Node Dissection with Immediate Lymphatic Reconstruction;   Procedure: Axillary Lymph Node Dissection without Immediate Lymphatic Reconstruction;   Other: quality-of-life questionnaires;   Other: measured by arm volume
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
A Study of Oral Tazemetostat in Subjects With Moderate and Severe Hepatic Impairment With Advanced Malignancies
Conditions:   Hepatic Impairment;   Advanced Malignant Solid Tumor
Intervention:   Drug: Tazemetostat
Sponsors:   Epizyme, Inc.;   Sponsor GmbH
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice
Condition:   Cancer
Intervention:   Device: Multi-Cancer Early Detection Test
Sponsor:   GRAIL, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
Conditions:   Sarcoma;   Advanced Sarcoma;   High Grade Sarcoma
Interventions:   Drug: DCC-3014;   Drug: Avelumab
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC
Conditions:   Cutaneous Squamous Cell Carcinoma;   Cutaneous Squamous Cell Carcinoma of the Head and Neck
Intervention:   Drug: Cemiplimab-Rwlc
Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Regeneron Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain
Conditions:   Chemotherapy-Induced Peripheral Neuropathy;   Malignant Neoplasm
Interventions:   Device: FitBit;   Other: Gait Assessment Test;   Other: MC5-A Scrambler Therapy;   Other: Quality-of-Life Assessment;   Procedure: Quantitative Sensory Testing;   Other: Questionnaire Administration
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
Serum-derived Bovine Immunoglobulin Effect on Mucositis
Condition:   Mucositis
Interventions:   Dietary Supplement: SBI;   Dietary Supplement: Placebo
Sponsor:   MercyOne Des Moines Medical Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Condition:   Neoplasms of the Prostate
Intervention:   Device: AuroShell particle infusion
Sponsor:   Nanospectra Biosciences, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Conditions:   Lymphoma Non-Hodgkin;   Agressive Lymphoma;   Diffuse-large B-cell Lymphoma (DLBCL)
Intervention:   Biological: CC-97540
Sponsor:   Juno Therapeutics, a Subsidiary of Celgene
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in